Eagle Pharmaceuticals, Inc. et al v. Hospira, Inc. > Summary
Court Case Number 1:18-cv-01074
Filing Date Jul 19, 2018
Termination Date Apr 19, 2022
Court Delaware District Court
Status Dismissed - Voluntarily
Defendant
Plaintiff Attorneys
30Eagle Pharmaceuticals, Inc.
Attorney Name: Daniel G. Brown
Latham & Watkins
Eagle Pharmaceuticals, Inc.
Attorney Name: Michelle L. Ernst
Latham & Watkins
Eagle Pharmaceuticals, Inc.
Attorney Name: Alex M. Grabowski
Latham & Watkins
Eagle Pharmaceuticals, Inc.
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
Eagle Pharmaceuticals, Inc.
Attorney Name: Karen E. Keller
Shaw Keller LLP
Eagle Pharmaceuticals, Inc.
Attorney Name: Kenneth G. Schuler
Latham & Watkins
Eagle Pharmaceuticals, Inc.
Attorney Name: John W. Shaw
Shaw Keller LLP
Eagle Pharmaceuticals, Inc.
Attorney Name: Marc N. Zubick
Latham & Watkins
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Elise M. Baumgarten
Williams & Connolly
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: David I. Berl
Williams & Connolly
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Adam D. Harber
Williams & Connolly
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Karen E. Keller
Shaw Keller LLP
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Shaun P. Mahaffy
Williams & Connolly
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Ben V. Picozzi
Williams & Connolly
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: John W. Shaw
Shaw Keller LLP
Cephalon (Teva)
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
Cephalon (Teva)
Attorney Name: Karen E. Keller
Shaw Keller LLP
Cephalon (Teva)
Attorney Name: John W. Shaw
Shaw Keller LLP
Eagle Pharmaceuticals, Inc.
Attorney Name: Alexandra M. Joyce
McCarter & English
Eagle Pharmaceuticals, Inc.
Attorney Name: Daniel M. Silver
McCarter & English
Eagle Pharmaceuticals, Inc.
Attorney Name: Angela Whitesell
McCarter & English
Eagle Pharmaceuticals, Inc.
Attorney Name: Angela Whitesell
DLA Piper
Eagle Pharmaceuticals, Inc.
Attorney Name: Lauren Sharkey
Latham & Watkins
Cephalon (Teva)
Attorney Name: Noel Norris
Eagle Pharmaceuticals, Inc.
Cephalon (Teva)
Attorney Name: Bruce Cheson
Eagle Pharmaceuticals, Inc.
Cephalon (Teva)
Attorney Name: Andrew Knill
Eagle Pharmaceuticals, Inc.
Cephalon (Teva)
Attorney Name: Edmund J. Elder
Eagle Pharmaceuticals, Inc.
Defendant Attorneys
23Hospira
Attorney Name: Aaron A. Barlow
Jenner & Block
Hospira
Attorney Name: Arthur G. Connolly III
Connolly Gallagher LLP
Hospira
Attorney Name: Yusuf Esat
Jenner & Block
Hospira
Attorney Name: Sara Horton
Jenner & Block
Hospira
Attorney Name: Ryan P. Newell
Connolly Gallagher LLP
Hospira
Attorney Name: Ren-How H. Harn
Willkie Farr & Gallagher
Hospira
Attorney Name: Sara Horton
Willkie Farr & Gallagher
Hospira
Attorney Name: Michael W. Johnson
Willkie Farr & Gallagher
Hospira
Attorney Name: Brandon R. Harper
Connolly Gallagher LLP
Hospira
Attorney Name: Stephanie S. Riley
Connolly Gallagher LLP
Hospira
Attorney Name: Kelly M. Conlan
Connolly Gallagher LLP
Hospira
Attorney Name: Alan R. Silverstein
Connolly Gallagher LLP
Hospira
Attorney Name: Leah Taylor
Hospira
Hospira
Attorney Name: Anne Christopher
Hospira
Hospira
Attorney Name: Srikanth Sundaram
Hospira
Hospira
Attorney Name: Steven Coutre
Stanford University
Hospira
Attorney Name: George Grass
Hospira
Hospira
Attorney Name: Gavin Halbert
Hospira
Hospira
Attorney Name: Robert J. Soiffer
Harvard University
Hospira
Attorney Name: Paul Bruinenberg
Hospira
Hospira
Attorney Name: Mary I. Akhimien
Connolly Gallagher LLP
Hospira
Attorney Name: Steven Krill
Hospira
Cause
35:271 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
10010533 | Formulations of bendamustine | Jul 3, 2018 |
09597397 | Formulations of bendamustine | Mar 21, 2017 |
09597398 | Formulations of bendamustine | Mar 21, 2017 |
09597399 | Formulations of bendamustine | Mar 21, 2017 |
09579384 | Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration | Feb 28, 2017 |
09572887 | Formulations of bendamustine | Feb 21, 2017 |
09144568 | Formulations of bendamustine | Sep 29, 2015 |
09034908 | Formulations of bendamustine | May 19, 2015 |
09000021 | Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration | Apr 7, 2015 |